LOS ANGELES, March 12, 2025 /PRNewswire/ -- Salt AI, founded by the high-performance computing (HPC) team behind MySpace, today announces its…
Content-Driven Program Brings Together Clinical Trial Stakeholders to Foster Knowledge Sharing and Collaboration in Cancer Research COLUMBIA, Md., March 12,…
Content-Driven Program Brings Together Clinical Trial Stakeholders to Foster Knowledge Sharing and Collaboration in Cancer Research COLUMBIA, Md., March 12,…
Harnessing generative AI to develop targeted therapies for DNA damage response, including hard-to-treat central nervous system malignanciesVANCOUVER, British Columbia, March…
Largest shareholder, CK Life Sciences Int’l., (Holdings) Inc. agrees to conversion of debt into equity, removing all existing debt from…
Encouraging Safety Profile Supports Progression Toward First Dual-Administration of Selective A2A and A2B Antagonists in PatientsDOVER, Del., March 12, 2025…
GAITHERSBURG, Md. and BASEL, Switzerland, March 12, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS), a leading public health…
Late-breaking clinical and first translational data from BOND-003 Cohort C will be presentedIRVINE, Calif., March 12, 2025 (GLOBE NEWSWIRE) --…
Trial for this rare genetic disease to be conducted by NIH/NIAID in partnership with Corvus ITK inhibition intended to address…
Dr. Anatoly Dritschilo remains Chairman of the Board and Co-CEO overseeing scientific and clinical trial activitiesGAITHERSBURG, Md., March 12, 2025…